NasdaqCM - Delayed Quote USD

ESSA Pharma Inc. (EPIX)

6.12 -0.13 (-2.08%)
At close: April 25 at 4:00 PM EDT
Loading Chart for EPIX
DELL
  • Previous Close 6.25
  • Open 6.18
  • Bid 4.57 x 200
  • Ask 7.75 x 200
  • Day's Range 5.92 - 6.43
  • 52 Week Range 2.56 - 11.67
  • Volume 64,765
  • Avg. Volume 126,600
  • Market Cap (intraday) 270.737M
  • Beta (5Y Monthly) 1.69
  • PE Ratio (TTM) --
  • EPS (TTM) -0.59
  • Earnings Date May 7, 2024 - May 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 19.00

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

www.essapharma.com

50

Full Time Employees

September 30

Fiscal Year Ends

Recent News: EPIX

Performance Overview: EPIX

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EPIX
7.27%
S&P 500
5.84%

1-Year Return

EPIX
125.83%
S&P 500
22.03%

3-Year Return

EPIX
77.51%
S&P 500
20.77%

5-Year Return

EPIX
163.00%
S&P 500
72.46%

Compare To: EPIX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EPIX

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    270.74M

  • Enterprise Value

    128.99M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -5.02

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -12.87%

  • Return on Equity (ttm)

    -17.05%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -25.8M

  • Diluted EPS (ttm)

    -0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    142.12M

  • Total Debt/Equity (mrq)

    0.27%

  • Levered Free Cash Flow (ttm)

    -15.17M

Research Analysis: EPIX

Analyst Price Targets

15.00
19.00 Average
6.12 Current
29.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: EPIX

Fair Value

6.12 Current
 

Dividend Score

0 Low
EPIX
Sector Avg.
100 High
 

Hiring Score

0 Low
EPIX
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
EPIX
Sector Avg.
100 High
 

Research Reports: EPIX

  • Daily – Vickers Top Buyers & Sellers for 11/17/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 01/06/2023

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 07/21/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 07/19/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch